The company said gross revenue surged 367% to C$75 million, $56 million, topping analyst estimates of C$67.5 million, $50.1 million.
It said its loss attributable to shareholders was $C158 million, $117 million.
The company said it is "well positioned to achieve positive EBITDA beginning in fiscal Q4."
Aurora did not break out an earnings-per-share number in the release.
Aurora Cannabis is a focus of the Stocks Under $10 portfolio. To find out more about how you can profit from this investing approach, please click here.